Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'schizophrenia treatment' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McCall, WV
      Electroconvulsive thera in the era of modern psychopharmacology

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Risch, SC; McGurk, S; Horner, MD; Nahas, Z; Owens, SD; Molloy, M; Gilliard, C; Christie, S; Markowitz, JS; DeVane, CL; Mintzer, J; George, MS
      A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: Functional MRI correlates

      NEUROCASE
    3. Chanpattana, W; Chakrabhand, MLS
      Factors influencing treatment frequency of continuation ECT in schizophrenia

      JOURNAL OF ECT
    4. Hirose, S; Ashby, CR; Mills, MJ
      Effectiveness of ECT combined with risperidone against aggression in schizophrenia

      JOURNAL OF ECT
    5. Kennedy, A; Jain, S; Vinogradov, S
      Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles

      FORMULARY
    6. Jones, A
      Hospital care pathways for patients with schizophrenia

      JOURNAL OF CLINICAL NURSING
    7. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    8. Silver, H; Shlomo, M
      Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction

      SCHIZOPHRENIA RESEARCH
    9. Rabinowitz, J; Davidson, M
      Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

      SCHIZOPHRENIA RESEARCH
    10. Belsham, B
      Glutamate and its role in psychiatric illness

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    11. Breitenstein, C; Van Lancker, D; Daum, I; Waters, CH
      Impaired perception of vocal emotions in Parkinson's disease: Influence ofspeech time processing and executive functioning

      BRAIN AND COGNITION
    12. Ozdemir, V; Kalow, W; Posner, P; Collins, EJ; Kennedy, JL; Tang, BK; Albers, LJ; Reist, C; Roy, R; Walkes, W; Afra, P
      CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    13. Lindenmayer, JP; Volavka, J; Lieberman, J; Sheitman, B; Citrome, L; Chakos, M; Czobor, P; Parker, B; Iskander, A
      Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    14. Glick, ID; Lemmens, P; Vester-Blokland, E
      Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    15. Iwanami, A; Okajima, Y; Isono, H; Shinoda, J; Kasai, K; Hata, A; Fukuda, M; Nakagome, K; Kamijima, K
      Effects of risperidone on event-related potentials in schizophrenic patients

      PHARMACOPSYCHIATRY
    16. Bhana, N; Foster, RH; Olney, R; Plosker, GL
      Olanzapine - An updated review of its use in the management of schizophrenia

      DRUGS
    17. Miller, DD; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD
      Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

      BIOLOGICAL PSYCHIATRY
    18. Green, MF; Braff, DL
      Translating the basic and clinical cognitive neuroscience of schizophreniato drug development and clinical trials of antipsychotic medications

      BIOLOGICAL PSYCHIATRY
    19. Goff, DC; Coyle, JT
      The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    20. Azorin, JM; Spiegel, R; Remington, G; Vanelle, JM; Pere, JJ; Giguere, M; Bourdeix, I
      A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    21. Chakos, M; Lieberman, J; Hoffman, E; Bradford, D; Sheitman, B
      Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials

      AMERICAN JOURNAL OF PSYCHIATRY
    22. Harvey, PD; Keefe, RSE
      Studies of cognitive change in patients with schizophrenia following novelantipsychotic treatment

      AMERICAN JOURNAL OF PSYCHIATRY
    23. Heresco-Levy, U
      N-methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    24. Hellewell, JSE; Gerlach, JES
      Opportunities and challenges presented by the new generation antipsychotics

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    25. Stip, E
      Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    26. Emsley, RA
      Role of newer atypical antipsychotics in the management of treatment-resistant schizophrenia

      CNS DRUGS
    27. Lindstrom, E; Bingefors, K
      Patient compliance with drug therapy in schizophrenia - Economic and clinical issues

      PHARMACOECONOMICS
    28. Worrel, JA; Marken, PA; Beckman, SE; Ruehter, VL
      Atypical antipsychotic agents: A critical review

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    29. Marder, SR
      Newer antipsychotics

      CURRENT OPINION IN PSYCHIATRY
    30. Frangou, S; Lewis, M
      Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service

      EUROPEAN PSYCHIATRY
    31. Weiser, M; Shneider-Beeri, M; Nakash, N; Brill, N; Bawnik, O; Reiss, S; Hocherman, S; Davidson, M
      Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?

      SCHIZOPHRENIA RESEARCH
    32. Sheitman, BB; Murray, MG; Snyder, JA; Silva, S; Goldman, R; Chakos, M; Volavka, J; Lieberman, JA
      IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness

      SCHIZOPHRENIA RESEARCH
    33. Carpenter, WT; Conley, R; Kirkpatrick, B
      On schizophrenia and new generation drugs

      NEUROPSYCHOPHARMACOLOGY
    34. Meltzer, H; Kostakaglu, E; Lee, M
      Response: Negative symptoms redux

      NEUROPSYCHOPHARMACOLOGY
    35. Davidson, M; Harvey, PD; Vervarcke, J; Gagiano, CA; De Hooge, JD; Bray, G; Dose, M; Barak, Y; Haushofer, M
      A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    36. Rivas-Vazquez, RA; Blais, MA; Rey, GJ; Rivas-Vazquez, AA
      Atypical antipsychotic medications: Pharmacological profiles and psychological implications

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    37. Chong, SA; Remington, G
      Clozapine augmentation: Safety and efficacy

      SCHIZOPHRENIA BULLETIN
    38. Angelucci, F; Mathe, AA; Aloe, L
      Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in ratbrain are significantly altered after haloperidol and risperidone administration

      JOURNAL OF NEUROSCIENCE RESEARCH
    39. Taylor, DM; Duncan-McConnell, D
      Refractory schizophrenia and atypical antipsychotics

      JOURNAL OF PSYCHOPHARMACOLOGY
    40. Emsley, RA; Raniwalla, J; Bailey, PJ; Jones, AM
      A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    41. Masaguer, CF; Ravina, E; Fontenla, JA; Brea, J; Tristan, H; Loza, MI
      Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: synthesis and determination of affinities at D-2, 5-HT2A, 5-HT2B and 5-HT2C receptors

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    42. Littrell, KH; Johnson, CG; Hilligoss, NM; Peabody, CD; Littrell, SH
      Switching clozapine responders to olanzapine

      JOURNAL OF CLINICAL PSYCHIATRY
    43. Buscema, CA; Abbasi, QA; Barry, DJ; Lauve, TH
      An algorithm for the treatment of schizophrenia in the correctional setting: The Forensic Algorithm Project

      JOURNAL OF CLINICAL PSYCHIATRY
    44. Conley, RR
      Risperidone side effects

      JOURNAL OF CLINICAL PSYCHIATRY
    45. Dossenbach, MRK; Beuzen, JN; Avnon, M; Belmaker, RH; Elizur, A; Mark, M; Munitz, H; Schneidman, M; Shoshani, D; Kratky, P; Grundy, SL; Tollefson, GD
      The effectiveness of olanzapine in treatment-refractory schizophrenia whenpatients are nonresponsive to or unable to tolerate clozapine

      CLINICAL THERAPEUTICS
    46. Harvey, PD
      Management of schizophrenia with cognitive impairment

      PSYCHIATRIC ANNALS
    47. Lindenmayer, JP
      Treatment refractory schizophrenia

      PSYCHIATRIC QUARTERLY
    48. Keltner, NL; Coffeen, H; Johnson, JE
      Atypical antipsychotic drugs: Part II

      PERSPECTIVES IN PSYCHIATRIC CARE
    49. Moller, HJ
      Current assessment of new/atypical neuroleptics

      NERVENARZT
    50. Schulz, SC
      New antipsychotic medications: More than old wine and new bottles

      BULLETIN OF THE MENNINGER CLINIC
    51. Buckley, PF
      Comprehensive disease management for schizophrenia

      DRUGS OF TODAY
    52. Duncan, GE; Miyamoto, S; Leipzig, JN; Lieberman, JA
      Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    53. Velakoulis, D; Wood, SJ; McGorry, PD; Pantelis, C
      Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    54. Remington, G; Kapur, S
      Atypical antipsychotics: are some more atypical than others?

      PSYCHOPHARMACOLOGY
    55. Amin, S
      Cost-effectiveness of atypical antipsychotics in chronic schizophrenia

      HOSPITAL MEDICINE
    56. Duncan, GE; Zorn, S; Lieberman, JA
      Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

      MOLECULAR PSYCHIATRY
    57. Koshino, Y
      Algorithm for treatment-refractory schizophrenia

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    58. Ito, C; Kubota, Y; Sato, M
      A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    59. Foster, RH; Goa, KL
      Olanzapine - A pharmacoeconomic review of its use in schizophrenia

      PHARMACOECONOMICS
    60. Chanpattana, W; Chakrabhand, S; Sackeim, HA; Kitaroonchai, W; Kongsakon, R; Techakasem, P; Buppanharun, W; Tuntirungsee, Y; Kirdcharoen, N
      Continuation ECT in treatment-resistant schizophrenia: A controlled study

      JOURNAL OF ECT
    61. Chanpattana, W; Chakrabhand, MLS; Kongsakon, R; Techakasem, P; Buppanharun, W
      Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia

      JOURNAL OF ECT
    62. Chanpattana, W
      Maintenance ECT in mentally retarded, treatment-resistant schizoprenic patients

      JOURNAL OF ECT
    63. Krystal, JH; D'Souza, DC; Madonick, S; Petrakis, IL
      Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    64. Rund, BR
      How do neuroleptics affect cognitive dysfunctions in schizophrenia?

      NORDIC JOURNAL OF PSYCHIATRY
    65. Dittert, S; Soyka, M; Winter, C; Moller, HJ
      Cognition and driving ability of schizophrenic patients on risperidone versus haloperidol

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    66. Dursun, SM; Gardner, DM; Bird, DC; Flinn, J
      Olanzapine for patients with treatment-resistant schizophrenia: A naturalistic case-series outcome study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    67. Blin, O
      A comparative review of new antipsychotics

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    68. Meltzer, HY; McGurk, SR
      The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

      SCHIZOPHRENIA BULLETIN
    69. Dawkins, K; Lieberman, JA; Lebowitz, BD; Hsiao, JK
      Antipsychotics: Past and future - National Institute of Mental Health Division of Services and Intervention Research Workshop, July 14, 1998

      SCHIZOPHRENIA BULLETIN
    70. Campbell, M; Young, PI; Bateman, DN; Smith, JM; Thomas, SHL
      The use of atypical antipsychotics in the management of schizophrenia

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. Green, B
      Focus on olanzapine

      CURRENT MEDICAL RESEARCH AND OPINION
    72. Fleischhacker, WW
      Clozapine: A comparison with other novel antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    73. Stahl, SM
      Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials

      JOURNAL OF CLINICAL PSYCHIATRY
    74. Buckley, PF
      New antipsychotic agents: Emerging clinical profiles

      JOURNAL OF CLINICAL PSYCHIATRY
    75. Osser, DN; Zarate, CA
      Consultant for the pharmacotherapy of schizophrenia

      PSYCHIATRIC ANNALS
    76. Meltzer, HY; Park, S; Kessler, R
      Cognition, schizophrenia, and the atypical antipsychotic drugs

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    77. Ravina, E; Negreira, J; Cid, J; Masaguer, CP; Rosa, E; Rivas, ME; Fontenla, JA; Loza, MI; Tristan, H; Cadavid, MI; Sanz, F; Lozoya, E; Carotti, A; Carrieri, A
      Conformationally constrained butyrophenones with mixed dopaminergic (D-2) and serotoninergic (5-HT2A, 5-HT2C) affinities: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics

      JOURNAL OF MEDICINAL CHEMISTRY
    78. Masaguer, CF; Casariego, I; Ravina, E
      Conformationally restricted butyrophenones with mixed dopaminergic (D-2) and serotoninergic (5-MT2A) affinities. Synthesis of 5-aminoethyl- and 6-aminomethyl-4-oxotetrahydroindoles as potential atypical antipsychotics

      CHEMICAL & PHARMACEUTICAL BULLETIN
    79. Kane, JM
      Pharmacologic treatment of schizophrenia

      BIOLOGICAL PSYCHIATRY
    80. Breier, A; Hamilton, SH
      Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

      BIOLOGICAL PSYCHIATRY
    81. Striebel, KM; Beyerstein, B; Remick, RA; Kopala, L; Honer, WG
      Olfactory identification and psychosis

      BIOLOGICAL PSYCHIATRY
    82. Carpenter, WT; Buchanan, RW; Kirkpatrick, B; Breier, AF
      Diazepam treatment of early signs of exacerbation in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    83. Rund, BR; Borg, NE
      Cognitive deficits and cognitive training in schizophrenic patients: a review

      ACTA PSYCHIATRICA SCANDINAVICA
    84. FOSTER RH; GOA KL
      RISPERIDONE - A PHARMACOECONOMIC REVIEW OF ITS USE IN SCHIZOPHRENIA

      PharmacoEconomics
    85. Fink, M
      ECT and clozapine in schizophrenia

      JOURNAL OF ECT
    86. GOFF DC; EVINS AE
      NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - NEUROBIOLOGICAL MODELS AND TREATMENT RESPONSE

      Harvard review of psychiatry
    87. LIN A; KENIS G; BIGNOTTI S; TURA GJB; DEJONG R; BOSMANS E; PIOLI R; ALTAMURA C; SCHARPE S; MAES M
      THE INFLAMMATORY RESPONSE SYSTEM IN TREATMENT-RESISTANT SCHIZOPHRENIA- INCREASED SERUM INTERLEUKIN-6

      Schizophrenia research
    88. GERACIOTI TD; PARKER S; LOWTHER NB; WORTMAN M; RICHTAND NM
      A CASE OF TREATMENT-REFRACTORY PSYCHOSIS RESPONSIVE TO SERTINDOLE

      Schizophrenia research
    89. Degner, D; Ruther, E
      "Atypical" antipsychotic drugs in the treatment of schizophrenia

      NERVENHEILKUNDE
    90. BRADFORD DW; CHAKOS MH; SHEITMAN BB; LIEBERMAN JA
      ATYPICAL ANTIPSYSHOTIC DRUGS IN TREATMENT-REFRACTORY SCHIZOPHRENIA

      Psychiatric annals
    91. SHARIF ZA
      TREATMENT-REFRACTORY SCHIZOPHRENIA - HOW SHOULD WE PROCEED

      Psychiatric quarterly
    92. Clark, AF; Lewis, SW
      Practitioner review: Treatment of schizophrenia in childhood and adolescence

      JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES
    93. TSAI GC; YANG PC; CHUNG LC; LANGE N; COYLE JT
      D-SERINE ADDED TO ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA

      Biological psychiatry
    94. VANELLE JM
      REFRACTORY SCHIZOPHRENIA - HISTORICAL AND CURRENTLY PREVAILING CRITERIA AND DEFINITIONS

      European psychiatry
    95. VANOS J; WRIGHT P; MURRAY RM
      FOLLOW-UP-STUDIES OF SCHIZOPHRENIA-I - NATURAL-HISTORY AND NON-PSYCHOPATHOLOGICAL PREDICTORS OF OUTCOME

      European psychiatry
    96. ALVAREZ E; BARON F; PEREZBLANCO J; SORIANO DPJ; MASIP C; PEREZSOLA V
      10 YEARS EXPERIENCE WITH CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIC-PATIENTS - FACTORS INDICATING THE THERAPEUTIC RESPONSE

      European psychiatry
    97. CASSANO GB; CIAPPARELLI A; VILLA M
      CLOZAPINE AS A TREATMENT TOOL - ONLY IN RESISTANT SCHIZOPHRENIC-PATIENTS

      European psychiatry
    98. LINDSTROM LH; LUNDBERG T
      LONG-TERM EFFECT ON OUTCOME OF CLOZAPINE IN CHRONIC THERAPY-RESISTANTSCHIZOPHRENIC-PATIENTS

      European psychiatry
    99. LUBLIN H
      TREATMENT-RESISTANT SCHIZOPHRENIA

      Nordic journal of psychiatry
    100. MELTZER HY
      TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CLOZAPINE

      Current medical research and opinion


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 04:20:42